|
#2
30.11.2007, 17:36
|
||||
|
||||
|
Óâû è àõ... Äåíåã õî÷óò
 Öèòàòà:
|
|
#4
30.11.2007, 18:18
|
|||
|
|||
Äà Âû ïðîñòî íà íèõ ðàáîòàåòå!
|
|
#7
30.11.2007, 18:28
|
|||
|
|||
|
ýòî ñ âàøåãî áåñïëàòíî, à ñ íàøåãî - çà äåíüãè. Åñëè ýòî ÷òî-òî èíòåðåñíîå, ïåðåøëèòå ïî ýë. ïî÷òå. Ñïàñèáî.
|
|
#9
30.11.2007, 20:55
|
|||
|
|||
|
ïðèâåäó îñíîâíûå öèòàòû, à âû óæ ñàìè ðåøèòå, íóæíà ëè âàì ïîëíàÿ ñòàòüÿ:-) (åñëè ÷òî, âûøëþ, ó ìåíÿ îíà ñêà÷èâàåòñÿ)
Vaginal discharge Des Spence, general practitioner1, Catriona Melville, specialist registrar, sexual and reproductive healthcare2 Box 1 Causes of vaginal discharge Non-infective Physiological Cervical ectopy Foreign bodies, such as retained tampon Vulval dermatitis Non-sexually transmitted infection Bacterial vaginosis Candida infections Sexually transmitted infection Chlamydia trachomatis Neisseria gonorrhoeae Trichomonas vaginalis Summary points Vaginal discharge is caused by non-sexually and sexually transmitted infections Non-sexually transmitted infections may not need treatment, but sexually transmitted ones must be treated and partners notified Recent research suggests that fewer women with untreated chlamydial infection may develop pelvic inflammatory disease than previously thought—only 1-5.6% Concurrent infection depends on the population studied Molecular techniques are more sensitive than culture but are expensive, do not provide antibiotic sensitivities, and results can remain positive after treatment Self taken vaginal swabs, urine samples, and clinical tampons show comparable results to traditional vaginal specimens
|
|
#10
30.11.2007, 20:57
|
|||
|
|||
|
Box 2 Triple swabs
High vaginal swab to identify bacterial vaginosis, Candida infections, and Trichomonas vaginalis Endocervical swab in transport medium (charcoal or non-charcoal) to diagnose gonorrhoea Endocervical swab for a chlamydial DNA amplification test to diagnose Chlamydia trachomatis Box 3 Management of vaginal infections Bacterial vaginosis Metronidazole 2 g as a single oral dose, metronidazole 400-500 mg twice daily for five to seven days, intravaginal clindamycin cream (2%) once daily for seven days, or intravaginal metronidazole gel (0.75%) once daily for five days4 The infection often recurs and acidic vaginal jelly (such as Relact from Kora Healthcare) may reduce relapse rates27 Partner notification not needed Vulvovaginal candidiasis Vaginal imidazole preparations (such as clotrimazole, econazole, miconazole—various preparations are available including single dose ones), or fluconazole 150 mg orally8 The role of alternative treatments like tea tree oil and yoghurt containing Lactobacillus acidophilus have not been evaluated9 Oral versus vaginal treatment depends on preference Treatment for candidiasis is available over the counter in the UK Partner notification not needed Chlamydia trachomatis Doxycycline 100 mg twice daily for seven days (contraindicated in pregnancy), azithromycin 1 g orally in a single dose (WHO recommends azithromycin in pregnancy but the British National Formulary advises against its use unless no alternatives are available)13 A test of cure is not indicated13 Partner notification required Gonorrhoea Cefixime 400 mg as a single oral dose or ceftriaxone 250 mg intramuscularly as a single dose16 Referral to a genitourinary medical unit is encouraged because of the existence of resistant strains of the organism16 A test of cure is not routinely indicated if an appropriately sensitive antibiotic has been given, symptoms have resolved, and there is no risk of reinfection16 Partner notification required Trichomonas vaginalis Metronidazole 2 g orally in a single dose or metronidazole 400-500 mg twice daily for five to seven days17 Partner notification required Readers should refer to BASHH guidelines, the British National Formulary, and local policies for full treatment options, including treatment in pregnancy Additional educational resources Resources for healthcare professionals British Association for Sexual Health and HIV ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] of guidelines on sexual health Clinical Evidence ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] medical resource for informing treatment decisions and improving patient care Faculty of Sexual and Reproductive Health Care ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] )—This organisation provides information and a clinical advisory service on sexual health Medical Foundation for AIDS and Sexual Health ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] )—This organisation works with policy makers and health professionals to promote excellence in the prevention and management of HIV and other sexually transmitted infections Resources for patients FPA ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] for professionals and patients. The leaflet "Bodyworks" is particularly useful Clinical Knowledge Summaries ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] based clinical knowledge on common conditions managed in primary and first contact care. The site provides useful information leaflets for patients Best Treatments ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] that rates thousands of health and medical treatments on the basis of how well they work
|
|
#11
03.12.2007, 14:54
|
|||
|
|||
|
Ýòî äåéñòâèòåëüíî íóæíàÿ âåùü. À ãëàâíîå - î÷åíü ñâîåâðåìåííàÿ. Áûë ïåðèîä, êîãäà èíôåêöèÿì óäåëÿëîñü äîâîëüíî ìíîãî âíèìàíèÿ â ñïåöèàëüíîé ëèòåðàòóðå, è êàçàëîñü áû, âñå âñå óæå âûó÷èëè. Íî êàê òîëüêî ðàññëàáèëèñü, (âñåãî-òî ëåò ïÿòü ïðîøëî) è ãäå îíè, ýòè çíàíèÿ è íàâûêè: òîëüêî ïàðó äíåé íàçàä îáùàëàñü ñ îäíîé î÷åíü ðàçóìíîé ïàðîé, êîòîðîé äâà ìåñÿöà âíóòðèâåííî êàïåëüíî ëå÷èëè óðåàïëàçìó. ×åðåç äåíü. (àâòîðñêàÿ ðàáîòà îäíîãî êîììåð÷åñêîãî ìåä öåíòðà Ìîñêâû).
|
|
#12
03.12.2007, 16:54
|
|||
|
|||
|
Ìíå èíòåðåñåí ñàì ïðèíöèï ðàáîòû ïîäîáíûõ çàâåäåíèé - âåäü íèêîìó çà ýòî íè÷åãî íå áûëî - ïîëíàÿ áåçíàêàçàííîñòü. Êòî-òî õîòÿ áû èõ êîíòðîëèðóåò, èëè ñâîÿ ðóêà - âëàäûêà?
|
Ëèíåéíûé âèä
